Allo seeks 'voluntary resignations' amid need for more funding - Light Reading
6 days ago • Google News
Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.
6 days ago • Google News
1 weeks ago • Google News
2 weeks ago • Google News